We have developed an assay for 0.2 macroglobulin in amniotic fluid, based on the technique of Fixed Time Kinetic Immunoturbidimetry. The assay is precise (CV 5% between assays) and has a detection limit of 0.4 mg/1. We have determined the reference ränge for a? macroglobulin from 100 amniotic fluid samples from none Neural Tube Defect pregnancies. The data indicates no significant Variation of c*2 macroglobulin with gestational age and that the results in none Neural Tube Defect pregnancies showed a narrow reference ränge with a mean of 1.67 mg/1 and + 2 SD ränge of 0.23-3.11 mg/1 (99 percentile = 3.65 mg/1). Results in 25 Neural Tube Defect pregnancies are presented.
Intfoduction
Amniotic fluid -fetoprotein measurements are widely used äs a follow up to maternal serum a-fetoprotein screening for the detection of neural tube defects. However amniotic fluid -fetoprotein estimations have their limitations. Levels decrease with l ) Present address; Department of Biochemistry, Oldchurch
Hospital, RomfonJ, Essex, U.K.
gestational age, and if a cut off level of 5 SD above the mean for normal pregnancies is taken, 10% of open spina bifida cases may be missed (1) . Raised amniotic fluid -fetoprotein levels are associated with threatened abortion, fetal death, exomphalos, congenital nephrosis, Turner's syndrome and several other disorders. There is a need for additional Information to improve the success rate for detection of neural tube defects and to identify cases with high results due to other causes.
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The use of concanavalin A affinity Chromatographie fractionation of a-fetoprotein (2), gel electrophoretic fractionation of cholinesterase activity (3) and ct2 macroglobulin estimations (4) have been proposed äs possible adjuncts to total amniotic fluid a-fetoprotein measurements in the identification of neural tube defects. The relative merits of the three additional tests in the evaluation of false positive, borderline and false negative total amniotic fluid a-fetoprotein results have been recently outlined (5, 6) .
Measurements of a2 macroglobulin in amniotic fluid have either involved "rocket" immunoelectrophoresis (4, 7) or continuous flow nephelometry (8) .
Rocket electrophoresis whilst being sensitive (detection limit 0.1 mg/1) is time consuming and imprecise compared with the newer techniques such äs Kinetic Immunoturbidimetry (9) which are rapid, automatable and almost äs sensitive.
This paper describes the development of an assay for amniotic fluid 02 macroglobulin by a Fixed Time Kinetic Immunoturbidimetric technique and the determination of reference values.
Materials and Methods

Instrumentation
In this study we used the LKB The first five tubes in a batch were Standards, followed by uhk nown samples. The data processor presented the Standard curve äs absorbance changes (corrected to a 10 mm path length) and äs a slope equation with a correlation coeffkient followed by the respective calculated results for each unknown sample. Alternativel y results can be calculated by graphical meäns, with use of the absorbance change during 120 seconds.
Before priming the reagent pump and tubing in the kinetic analysê r, we filled the tubing with working antiserum solution and äÜ lowed it to equilibrate for 10 minutes, the solution was then returned to the reagent bottle and the tubing re-primed.
For comparison purposes the method used was a modification of the electroimmunoassay method of Laufell (10), using the Seward antiserum.
Tab. l, Assay settings for amniotic fluid 0:2 macroglobulin assay. 
Antiserum
Results
Several factors affect the antigen/antibody reaction and these have been described in detail elsewhere (9, 11, 12, 13) . Reäctiofi conditions investigated include pH, temperature, sodium chlöride concentration and polymer (polyethylene glycol 6000) concentration. Each parameter was shown to have similar optima tö those indicated for other assays (9, 11-13).
The calibration curves for four separate assays are sümmärised in figure 1 . The recorder Output from a typical calibrätion curve is shown in figure 2 , alongŝ ide three samples -sample A from a normal pfegn ancy, sample B from an neural tube defect pregn ancy with an 012 macroglobulin level within the ränge of the assay, sample C from a neural tube defect pregnancy with an 012 macroglobülin level out- side the ränge of the assay. Curve C is a characteristic curve for a sample which has produced an antigen excess Situation and äs such is instantly recognisable and would be repeated with subsequent dilution of the sample.
Detection limit
The minimum detectable concentration of macroglobulin in the assay System was determined by diluting a high neural tube defect specimen with a solution of human serum albumin (10 g/l). The detection limit corresponded to an 0.2 macroglobulin concentration of 0.4 mg/1 giving an absorbance change of 0.005 A per 120 secoiids.
Method performance
Precision
Within run precision of the assay System was assessed by measuring replicates (n = 20) of three samples with different a 2 macroglobulin levels; at 1.1 mg/1 the CV was 5.8%, at 3.1 mg/1 the CV was 4.7% and at 23.8 mg/1 the CV was 1.9%.
Between run precision was assessed by analysing separate frozen aliquöts (n = 10) of the samples. On each occasion a fresh dilution of antiserum was prepared. At a concentration of 3.4 mg/1 the CV was 5.2% and 2.8% at 24.6 mg/1.
Accuracy
The IFCC Expert Panel on Nomenclature and Principles of Quality Control in Clinical Chemistry (14) recommends that method accuracy be assessed by using recovery checks with pure analyte and also by comparing the values obtained with samples assayed by a method of known accuracy. Because there is no internationally agreed upon Standard or pure az macroglobulin available, accuracy could only be assessed by the latter method.
We compared patient samples analysed by the proposed method with the electroimmunoassay procedure. The regression parameters according to the Deming procedure were; y = 0.89 + 0.05 (r = 0.918, n = 40).
Reference ränge
Amniotic fluid specimens over a wide ränge of gestational age were kindly supplied by the Regional Centre, Department of Cytogenetics, Salisbury General Infirmary and were stored at -20 °C prior to analysis. Detailed study of the patients notes were taken . after the birth to exclude any potentially abnormal samples. The samples were analysed for 0.2 macroglobulin concentration spread over six separate assays. The mean results for each weck of pregnancy are shown in table 2 and the individual results plotted on a log scale in figure 3 . These results indicate a very narrow normal ränge, with an overall mean level öf 1.67 mg/1, +2 SD ränge of 0.23-3.11 mg/1 and a 99th centile of 3.65 mg/1. Furthermore the levels are independent of gestational age. These findings agree very closely with those of Haddow et al. (8) who also showed a mean of l .7 mg/1 and Van Kamp et al. (7) who also showed that levels were independent of gestational age. 
Conclusions
A quick reliable assay for 0.2 macroglobulin has been developed and assessed using the technique of Fixed Time Kinetic Immunoturbidimetry. The reference ränge frpm 97 normal pregnancies has been shown to be 0.23-3.11 mg/1 (mean -2 SD, 99tti centile 3.65 mg/1). The test has proven useful in providing additional Information concerning the likely outcome of pregnancies presenting with equivocal ainniotic fluid -fetoprotein levels. The data concerning this clinical study has been preseiited elsewhere (5, 6) . The main drawbaek to the use of 0.2 macroglobulin assays in this way lies in the potential interference by maternal blood contamination since levels of 0.2 macroglobulin are 10 3 fold greater in maternal serum (4). Prior screening of samples for blood coiitä-minatiön excluded such samples from contributing to the reference ränge. 
